Melior Discovery, Inc. is a private biopharmaceutical company based in Exton, Pennsylvania, USA. The company specializes in drug repositioning

Drug repositioning

Drug repositioning is the application of known drugs and compounds to new indications .- Drug repositioning :...

 and has established a technology it uses for this purpose. According to the company’s website, Melior also offers certain contract research organization

Contract research organization

A contract research organization, also called a clinical research organization, is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services...

 (CRO) services comprising animal models representing different disease conditions. The Company has issued press releases disclosing partnerships with Pfizer

Pfizer

Pfizer, Inc. is an American multinational pharmaceutical corporation. The company is based in New York City, New York with its research headquarters in Groton, Connecticut, United States...

, Merck & Co.

Merck & Co.

Merck & Co., Inc. , also known as Merck Sharp & Dohme or MSD outside the United States and Canada, is one of the largest pharmaceutical companies in the world. The Merck headquarters is located in Whitehouse Station, New Jersey, an unincorporated area in Readington Township...

, Johnson & Johnson

Johnson & Johnson

Johnson & Johnson is an American multinational pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500....

 and AstraZeneca

AstraZeneca

AstraZeneca plc is a global pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world's seventh-largest pharmaceutical company measured by revenues and has operations in over 100 countries...

, all citing the use of the company’s drug repositioning technology. Melior Discovery has also used its technology to discover its own drug candidates. In March 2009 the Food and Drug Administration

Food and Drug Administration

The Food and Drug Administration is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments...

 (FDA) approved the company’s Investigational New Drug

Investigational New Drug

The United States Food and Drug Administration's Investigational New Drug program is the means by which a pharmaceutical company obtains permission to ship an experimental drug across state lines before a marketing application for the drug has been approved...

(IND) application for a type 2 diabetes therapeutic candidate.

	Company Information
Type	Private
Founded	2005
Industry	Biotechnology
Services	Biotechnology, contract research organization
Website	www.meliordiscovery.com

History

Melior Discovery was co-founded in 2005 by Dr Andrew Reaume (President and CEO) and Dr. Michael Saporito (Vice President of Research) . Its investors include Cammeby’s Capital Group, VenturEast, Osage Ventures, Mid-Atlantic Angel Group, and BioAdvance.

External links

1. Melior Discovery Website

2. Melior Discovery- Company Profile

3. GEN Article: "Repositioning Idle Drugs via Systematic Serendipity"

4. NGP Article: "Teaching an old drug new tricks…"